Dnmt3b is a haploinsufficient tumor suppressor gene in Myc-induced lymphomagenesis

Blood

Volumn 121, Issue 11, 2013, Pages 2059-2063

  Vasanthakumar, Aparna ^a   Lepore, Janet B ^a   Zegarek, Matthew H ^a   Kocherginsky, Masha ^b   Singh, Mahi ^a   Davis, Elizabeth M ^a   Link, Petra A ^b   Anastasi, John ^c   Le Beau, Michelle M ^a,b   Karpf, Adam R ^b   Godley, Lucy A ^a,b  

^a SECTION OF HEMATOLOGY ONCOLOGY   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DNA METHYLTRANSFERASE 1; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; DNA (CYTOSINE 5) METHYLTRANSFERASE; ISOPROTEIN; MYC PROTEIN; MYC PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CARCINOGENESIS; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENE DOSAGE; GENE EXPRESSION; GENE MUTATION; HAPLOINSUFFICIENCY; MALE; MOUSE; NONHUMAN; ONCOGENE C MYC; PRE B LYMPHOCYTE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; ANIMAL; BIOLOGICAL MODEL; C57BL MOUSE; CELL TRANSFORMATION; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROMOTER REGION; TRANSGENIC MOUSE;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; DNA (CYTOSINE-5-)-METHYLTRANSFERASE; DNA METHYLATION; GENES, TUMOR SUPPRESSOR; HAPLOINSUFFICIENCY; LYMPHOMA, B-CELL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MODELS, BIOLOGICAL; PROMOTER REGIONS, GENETIC; PROTEIN ISOFORMS; PROTO-ONCOGENE PROTEINS C-MYC;

MLCS; MLOWN;

EID: 84877595762     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-04-421065     Document Type: Article

References (21)

1. Sharma S, Kelly TK, Jones PA. Epigenetics in cancer. Carcinogenesis. 2010;31(1):27-36.
2. Bestor TH. The DNA methyltransferases of mammals. Hum Mol Genet. 2000;9(16): 2395-2402.
3. Wang J, Walsh G, Liu DD, et al. Expression of Delta DNMT3B variants and its association with promoter methylation of p16 and RASSF1A in primary non-small cell lung cancer. Cancer Res. 2006;66(17):8361-8366.
4. Ostler KR, Davis EM, Payne SL, et al. Cancer cells express aberrant DNMT3B transcripts encoding truncated proteins. Oncogene. 2007;26 (38):5553-5563.
5. Shah MY, Vasanthakumar A, Barnes NY, et al. DNMT3B7, a truncated DNMT3B isoform expressed in human tumors, disrupts embryonic development and accelerates lymphomagenesis. Cancer Res. 2010;70(14):5840-5850.
6. Adams JM, Harris AW, Pinkert CA, et al. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature. 1985;318(6046): 533-538.
7. Okano M, Bell DW, Haber DA, et al. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell. 1999;99(3):247-257.
8. Ueda Y, Okano M, Williams C, et al. Roles for Dnmt3b in mammalian development: a mouse model for the ICF syndrome. Development. 2006; 133(6):1183-1192.
9. Van Emburgh BO, Robertson KD. Modulation of Dnmt3b function in vitro by interactions with Dnmt3L, Dnmt3a and Dnmt3b splice variants. Nucleic Acids Res. 2011;39(12):4984-5002.
10. Song L, James SR, Kazim L, et al. Specific method for the determination of genomic DNA methylation by liquid chromatography-electrospray ionization tandem mass spectrometry. Anal Chem. 2005;77(2):504-510.
11. Hlady RA, Novakova S, Opavska J, et al. Loss of Dnmt3b function upregulates the tumor modifier Ment and accelerates mouse lymphomagenesis. J Clin Invest. 2012;122(1):163-177.
12. Gao Q, Steine EJ, Barrasa MI, et al. Deletion of the de novo DNA methyltransferase Dnmt3a promotes lung tumor progression. Proc Natl Acad Sci USA. 2011;108(44):18061-18066.
13. Yamashita Y, Yuan J, Suetake I, et al. Array-based genomic resequencing of human leukemia. Oncogene. 2010;29(25):3723-3731.
14. Ley TJ, Ding L, Walter MJ, et al. DNMT3A mutations in acute myeloid leukemia. N Engl J Med. 2010;363(25):2424-2433.
15. Yan XJ, Xu J, Gu ZH, et al. Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia. Nat Genet. 2011;43(4):309-315.
16. Opavsky R, Wang SH, Trikha P, et al. CpG island methylation in a mouse model of lymphoma is driven by the genetic configuration of tumor cells. PLoS Genet. 2007;3(9):1757-1769.
17. Shaknovich R, Cerchietti L, Tsikitas L, et al. DNA methyltransferase 1 and DNA methylation patterning contribute to germinal center B-cell differentiation. Blood. 2011;118(13): 3559-3569.
18. Brenner C, Deplus R, Didelot C, et al. Myc represses transcription through recruitment of DNA methyltransferase corepressor. EMBO J. 2005;24(2):336-346.
19. Perini G, Diolaiti D, Porro A, et al. In vivo transcriptional regulation of N-Myc target genes is controlled by E-box methylation. Proc Natl Acad Sci USA. 2005;102(34):12117-12122.
20. Palakurthy RK, Wajapeyee N, Santra MK, et al. Epigenetic silencing of the RASSF1A tumor suppressor gene through HOXB3-mediated induction of DNMT3B expression. Mol Cell. 2009; 36(2):219-230.
21. Zuber J, Shi J, Wang E, et al. RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Nature. 2011;478(7370): 524-528.